James D - Search Results

1

Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England.

Hope R, Warner M, Potz NA, Fagan EJ, James D, Livermore DM. Hope R, et al. Among authors: james d. J Antimicrob Chemother. 2006 Dec;58(6):1312-4. doi: 10.1093/jac/dkl414. Epub 2006 Oct 11. J Antimicrob Chemother. 2006. PMID: 17035342 No abstract available.

2

Zone breakpoints, by the CLSI disc method, for 15 μg tigecycline discs corresponding to EUCAST MIC breakpoints.

Hope R, Pllana T, James D, Warner M, Livermore DM. Hope R, et al. Among authors: james d. J Antimicrob Chemother. 2010 Oct;65(10):2262-4. doi: 10.1093/jac/dkq288. Epub 2010 Aug 4. J Antimicrob Chemother. 2010. PMID: 20685753 No abstract available.

3

Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK.

Hope R, Mushtaq S, James D, Pllana T, Warner M, Livermore DM; Tigecycline Susceptibility Testing Group. Hope R, et al. Among authors: james d. J Antimicrob Chemother. 2010 Dec;65(12):2602-9. doi: 10.1093/jac/dkq370. Epub 2010 Oct 7. J Antimicrob Chemother. 2010. PMID: 20930043

4

Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method.

Hope R, Parsons T, Mushtaq S, James D, Livermore DM. Hope R, et al. Among authors: james d. J Antimicrob Chemother. 2007 Oct;60(4):770-4. doi: 10.1093/jac/dkm297. Epub 2007 Aug 18. J Antimicrob Chemother. 2007. PMID: 17704517

5

Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, Towner KJ, Livermore DM, Woodford N. Henwood CJ, et al. Among authors: james d. J Antimicrob Chemother. 2002 Mar;49(3):479-87. doi: 10.1093/jac/49.3.479. J Antimicrob Chemother. 2002. PMID: 11864948

6

Activity of ertapenem against Neisseria gonorrhoeae.

Livermore DM, Alexander S, Marsden B, James D, Warner M, Rudd E, Fenton K. Livermore DM, et al. Among authors: james d. J Antimicrob Chemother. 2004 Jul;54(1):280-1. doi: 10.1093/jac/dkh272. Epub 2004 Jun 2. J Antimicrob Chemother. 2004. PMID: 15175267 No abstract available.

7

Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.

Livermore DM, Mushtaq S, Warner M, James D, Kearns A, Woodford N. Livermore DM, et al. Among authors: james d. J Antimicrob Chemother. 2015 Oct;70(10):2844-53. doi: 10.1093/jac/dkv179. Epub 2015 Jul 4. J Antimicrob Chemother. 2015. PMID: 26142478

8

Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint.

Livermore DM, Mushtaq S, Warner M, James D, Woodford N. Livermore DM, et al. Among authors: james d. J Antimicrob Chemother. 2015 Dec;70(12):3259-66. doi: 10.1093/jac/dkv265. Epub 2015 Aug 27. J Antimicrob Chemother. 2015. PMID: 26318188

9

Increasing prevalence of methicillin resistance amongst Staphylococcus aureus blood culture isolates.

Johnson AP, James D, Livermore DM. Johnson AP, et al. Among authors: james d. J Antimicrob Chemother. 1999 Jan;43(1):160. doi: 10.1093/jac/43.1.160. J Antimicrob Chemother. 1999. PMID: 10381119 No abstract available.

10

Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A. Henwood CJ, et al. Among authors: james d. J Antimicrob Chemother. 2000 Dec;46(6):931-40. doi: 10.1093/jac/46.6.931. J Antimicrob Chemother. 2000. PMID: 11102412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,774 results

Search Page

Filters